Denbri 60mg Denosumab Injection

Denbri 60mg Denosumab Injection is a prescription medication used to treat osteoporosis and other bone-related conditions in individuals at high risk of fractures. It contains Denosumab, a monoclonal antibody that works by blocking RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand), a protein that promotes bone breakdown. By reducing bone resorption, Denbri 60mg Denosumab Injection helps increase bone mineral density, strengthen bones, and lower the risk of fractures. Administered as a subcutaneous injection under the supervision of a healthcare professional, it is often prescribed as part of a comprehensive bone health management plan. Regular monitoring of calcium levels and bone health is important during treatment to ensure safety and effectiveness. Patients should use Denbri 60mg Denosumab Injection only as directed by their healthcare provider.